CP-730330

N/A

Report date: 2022/01/14 13:23:58
NME

Base Information

Drug NameCP-730330
Drug Alias NameCP-730330
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionGABA-A receptor; benzodiazepine site agonists
TargetsGABA-A receptor; benzodiazepine site
Therapy Area/IndicationsSleep Wake Disorders
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryN/A
CombinationsNo
Global Highest StatusDiscontinued (Phase 2 Clinical)
Highest Status in ChinaN/A
Originator CompaniesPfizer Inc
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesPfizer Inc
Active IndicationsN/A
Inactive IndicationsSleep Wake Disorders

Other Information

ATC CodeN/A
Related LinksN/A